Modeling epithelial and endothelial cell tropism for SARS-CoV-2 through restricted transgenic hACE2 expression in mice
Authors:
- Sahine LameireSLSahine Lameire
- Nincy DebeufNDNincy Debeuf
- Julie DeckersJDJulie Deckers
- Caroline De WolfCWCaroline De Wolf
- Manon VanheerswynghelsMVManon Vanheerswynghels
- Wendy ToussaintWTWendy Toussaint
- Lize De VliegerLVLize De Vlieger
- Lien Van HoeckeLHLien Van Hoecke
- Sieglinde De CaeSCSieglinde De Cae
- Bert SchepensBSBert Schepens
- Stijn VanheeSVStijn Vanhee
- Bart N. LambrechtBLBart N. Lambrecht
Preprint
Abstract
Given the ongoing evolution of SARS-CoV-2 and the historical emergence of other highly transmissible coronaviruses like SARS-CoV and HCoV-NL63, in vivo coronavirus research remains crucial even when the COVID-19 pandemic is receding. Due to restricted tropism of SARS-CoV-2 and other coronaviruses for mouse cells, model systems of infection rely on transgenic expression of the entry receptor human ACE2 (hACE2). Available hACE2 transgenic models using the Krt18 promotor express the receptor across multiple cell types and organ systems, leading to multiple disease features including pneumonia, vascular compromise and neuro-inflammation, that reflect the multi-organ nature of COVID-19. To disentangle the role of cell tropism in driving the clinical manifestations of the disease, we generated two new transgenic mouse models, Sftpa1 -hACE2 and Cdh5 -hACE2 transgenic mice, with hACE2 restricted to lung epithelium or endothelial cells respectively. In Sftpa1 -hACE2 mice, with high expression of the hACE2 receptor in lung alveolar type 2 cells, SARS-CoV-2 infection led to rapidly progressing disease, characterised by a strong neutrophilic innate immune response in the lung, followed by viral neuro-invasion and early death. Krt18 -hACE2 mice additionally recruited various dendritic cell subsets and gradually developed adaptive immunity. In Cdh5 -hACE2 Tg mice with exclusive endothelial tropism of the virus, viral inoculation via the lung or systemic circulation did not lead to viral propagation or disease manifestations, despite endothelial expression of hACE2 in the lung. These results suggest that tropism for alveolar epithelial cells increases disease severity, while endothelial cell tropism per se does not drive the vascular consequences often seen in COVID-19 patients. Our new transgenic mouse models will be helpful to dissect how cell tropism contributes to the clinical manifestations of coronavirus infection.Keywords
This publication has 45 references indexed in Scilit:
- Surfactant protein A modulates neuroinflammation in adult mice upon pulmonary infectionBrain Research, 2024
- Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infectionMammalian Genome, 2024
- Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemicCell, 2023
- SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse modelsCell Reports, 2022
- A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory MiceCell, 2020
- A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing AntibodiesCell, 2020
- Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and TreatmentCell, 2020
- Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2Cell, 2020
- Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus InfectionImmunity, 2020
- A Systems Analysis Identifies a Feedforward Inflammatory Circuit Leading to Lethal Influenza InfectionCell, 2013